In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice…
Chris Parry
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
After raising over $5 million over the last few weeks, identity verification cybersecurity company Plurilock (PLUR.V) has immediately put some of that cash into expanding its direct sales team….
At a time when many cannabis companies are enjoying bursts of investor interest, management at BC-based extractor Pure Extracts (PULL.C) must be getting frustrated as they roll out new…
Adopting a sin as an acceptable, taxable business is slow going. From the moment our government overlords decide to un-ban a thing, it takes often years, even decades, to…
Cannabis hard tablet IP holder Canntab Therapeutics (PILL.C) continues to send product to market, announcing Wednesday they’ve fulfilled 80% of their contract with Medipharm Labs (LABS.T), bringing in another…
For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years….
If International Montoro Resources Inc. didn’t exactly roll off your tongue, rejoice! for Marvel Discovery (MARV.V) is now a thing. While the name may earn some cred from the…
Do you ever get that feeling that you’ve written a story before? Weeks before and months before, and five times before and eight times before that? Whenever I see…
Confused over whether you want to invest in gold explorers or battery metals? Wondering whether it’s time to get into nickel, copper, or cobalt? Do titanium, vanadium, and chromium…